VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CICigna Corporation
$286.62$75.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCIPrice Target
CI logo

Cigna Corporation (CI) Price Target Analysis

Updated Jul 2, 2026
Analyst Rating: Buy
Based on 39 analysts

18.9% Below Target

CI trades 18.9% below Wall Street's consensus target of $340.91.

Current Price$286.62
Average Target$340.91
Target
Current
Low$302.00
Median$340.00
High$400.00

Analyst Target Range

Forward P/E9.4x
(Value)
PEG Ratio—
Implied Growth+28.0%
(High Growth)
Analyst Spread28.7%
(High Agreement)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$286.62
Consensus$340.91
High$400.00
Low$302.00

Consensus Scenario Assumptions

The base valuation assumes CI achieves its forward estimates and maintains a stable P/E multiple of 9.4x. This scenario reflects the blended consensus of 39 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 39 published analyst recommendations for CI

30/39 analysts are bullish
+40
BearishBullish
Weighted analyst sentiment score based on 39 ratings
ConsensusBuy
Coverage39 Analysts
Net Score+40
Bull / Bear77% / 0%
Strong Buy13%
Buy2974%
Hold923%
Sell00%
Strong Sell00%
Strong Buy
13%
Buy
2974%
Hold
923%
Sell
00%
Strong Sell
00%
Recommendation Mix77% Buy · 23% Hold · 0% Sell
Buy (30)Hold (9)Sell (0)

CI Price Target Analysis

Updated July 8, 2026

As of July 8, 2026, Cigna Corporation (CI) has a Wall Street consensus price target of $340.91, based on estimates from 39 covering analysts. With the stock currently trading at $286.62, this represents a potential upside of +18.9%. The company has a market capitalization of $75.57B.

Analyst price targets range from a low of $302.00 to a high of $400.00, representing a 29% spread in expectations. The median target of $340.00 aligns closely with the consensus average.

The current analyst consensus rating is Buy, with 30 analysts rating the stock as a Buy or Strong Buy,9 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.

From a valuation perspective, CI trades at a trailing P/E of 12.9x and forward P/E of 9.4x. Analysts expect EPS to grow +28.0% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $434.24, with bear and bull scenarios of $273.57 and $572.15 respectively. Model confidence stands at 54/100, reflecting moderate uncertainty in projections.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside
-2.6%
Industry Consensus
Avg Forward P/E
23.4x
(Fair)
Peers with Coverage
10 / 10
Active Analyst Tracking
CompanyMarket CapPriceTargetUpside PotentialRatingFwd P/EAnalysts
UNH logo
UNHUnitedHealth Group Incorporated
$388.9B$428.19$426.75
-0.3%
Buy23.3x52
ELV logo
ELVElevance Health Inc.
$91.0B$418.85$419.75
+0.2%
Buy15.6x37
CVS logo
CVSCVS Health Corporation
$133.1B$104.33$103.64
-0.7%
Buy14.1x41
HUM logo
HUMHumana Inc.
$47.4B$394.62$298.50
-24.4%
Hold44.6x44
CNC logo
CNCCentene Corporation
$32.6B$66.12$59.79
-9.6%
Buy18.9x43
MOH logo
MOHMolina Healthcare, Inc.
$12.1B$232.90$178.92
-23.2%
Buy45.4x38
ESNT logo
ESNTEssent Group Ltd.
$6.0B$64.60$66.25
+2.6%
Buy9.0x19
MCK logo
MCKMcKesson Corporation
$97.0B$807.33$994.86
+23.2%
Buy18.2x31
CAH logo
CAHCardinal Health, Inc.
$56.4B$239.71$253.38
+5.7%
Buy22.3x33
HCSG logo
HCSGHealthcare Services Group, Inc.
$1.7B$24.39$24.50
+0.5%
Hold22.5x15

CI — Frequently Asked Questions

Quick answers to the most common questions about buying CI stock.

What is the CI stock price target for 2026?

Cigna Corporation (CI) has a consensus 12-month price target of $340.91, implying 18.9% upside from $286.62. The 39 analysts covering CI see moderate appreciation potential.

Is CI a buy, sell, or hold?

CI has a consensus rating of "Buy" based on 39 Wall Street analysts. The rating breakdown is predominantly bullish, with 30 Buy/Strong Buy ratings. The consensus 12-month price target of $340.91 implies 18.9% upside from current levels.

Is CI stock overvalued or undervalued?

With a forward P/E of 9.412x, CI trades at a relatively low valuation. The consensus target of $340.91 implies 18.9% appreciation, suggesting meaningful undervaluation.

How high can CI stock go?

The most bullish Wall Street analyst has a price target of $400 for CI, while the most conservative target is $302. The consensus of $340.91 represents the median expectation. Our quantitative valuation model projects a bull case target of $572 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover CI stock?

CI is heavily covered by Wall Street, with 39 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 29 have Buy ratings, 9 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the CI stock forecast?

The 12-month CI stock forecast based on 39 Wall Street analysts shows a consensus price target of $340.91, with estimates ranging from $302 (bear case) to $400 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $434, with bear/bull scenarios of $274/$572.

What is CI's fair value based on fundamentals?

Our quantitative valuation model calculates CI's fair value at $434 (base case), with a bear case of $274 and bull case of $572. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 54/100.

What is CI's forward P/E ratio?

CI trades at a forward P/E ratio of 9.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 12.9x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy CI stock?

Wall Street analysts are optimistic on CI, with a "Buy" consensus rating and $340.91 price target (18.9% upside). 30 of 39 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do CI price targets vary so much?

CI analyst price targets range from $302 to $400, a 29% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $340.91 consensus represents the middle ground. Our model's $274-$572 range provides an independent fundamental perspective.

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare